272786-83-1 Usage
Description
Pyrrolo[1,2-a]pyrazin-6(2H)-one, hexahydro-7-methyl-, (7R,8aR)-rel(9CI) is a heterocyclic chemical compound with a complex molecular structure. It is a pyrazinone derivative featuring a hexahydro-7-methyl moiety and an (7R,8aR)-rel stereochemistry. Pyrrolo[1,2-a]pyrazin-6(2H)-one, hexahydro-7-methyl-, (7R,8aR)-rel(9CI) is of interest in the pharmaceutical industry due to its potential biological activities and unique structural features, making it a promising candidate for drug discovery and development.
Uses
Used in Pharmaceutical Industry:
Pyrrolo[1,2-a]pyrazin-6(2H)-one, hexahydro-7-methyl-, (7R,8aR)-rel(9CI) is used as a compound of interest for drug discovery and development due to its potential biological activities and unique structure. Its specific stereochemistry and heterocyclic nature may contribute to its potential applications in the treatment of various medical conditions, although further research and study are required to fully understand its properties and uses.
Check Digit Verification of cas no
The CAS Registry Mumber 272786-83-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,2,7,8 and 6 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 272786-83:
(8*2)+(7*7)+(6*2)+(5*7)+(4*8)+(3*6)+(2*8)+(1*3)=181
181 % 10 = 1
So 272786-83-1 is a valid CAS Registry Number.
272786-83-1Relevant articles and documents
Design, synthesis, and preliminary pharmacological evaluation of 1,4- diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents
Manetti, Dina,Ghelardini, Carla,Bartolini, Alessandro,Bellucci, Cristina,Dei, Silvia,Galeotti, Nicoletta,Gualtieri, Fulvio,Romanelli, Maria Novella,Scapecchi, Serena,Teodori, Elisabetta
, p. 1969 - 1974 (2007/10/03)
Several 4-substituted 1,4-diazabicyclo[4.3.0]nonan-9-ones have been synthesized and tested in vivo on mouse passive avoidance test, to evaluate their nootropic activity. The results show that they represent a new class of nootropic drugs with a pharmacolo
